You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Pharma & Healthcare

Global Intravenous(IV) Therapy and Vein Access Market Professional Research Report 2021-2027

Market Analysis and Insights: Global Intravenous(IV) Therapy and Vein Access Market
The research report studies the Intravenous(IV) Therapy and Vein Access market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Intravenous(IV) Therapy and Vein Access market size is projected to reach US$ 46480 million by 2027, from US$ 35670 million in 2020, at a CAGR of 3.4% during 2021-2027.
Global Intravenous(IV) Therapy and Vein Access Scope and Segment
The global Intravenous(IV) Therapy and Vein Access market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Intravenous(IV) Therapy and Vein Access market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
Infusion Pumps
Implantable Ports
Intravenous Catheters
Hypodermic Needles
Other
by Application, this report covers the following segments
Hospital
Clinics
Other
Global Intravenous(IV) Therapy and Vein Access market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Intravenous(IV) Therapy and Vein Access key players in this market include:
B. Braun
Baxter International
Becton Dickinson
C. R. Bard
Fresenius Kabi
Hospira(ICU Medical)
Medtronic
Smiths Group
Teleflex
1 Market Overview of Intravenous(IV) Therapy and Vein Access
1.1 Intravenous(IV) Therapy and Vein Access Market Overview
1.1.1 Intravenous(IV) Therapy and Vein Access Product Scope
1.1.2 Intravenous(IV) Therapy and Vein Access Market Status and Outlook
1.2 Global Intravenous(IV) Therapy and Vein Access Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Intravenous(IV) Therapy and Vein Access Market Size by Region (2016-2027)
1.4 Global Intravenous(IV) Therapy and Vein Access Historic Market Size by Region (2016-2021)
1.5 Global Intravenous(IV) Therapy and Vein Access Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Intravenous(IV) Therapy and Vein Access Market Size (2016-2027)
1.6.1 North America Intravenous(IV) Therapy and Vein Access Market Size (2016-2027)
1.6.2 Europe Intravenous(IV) Therapy and Vein Access Market Size (2016-2027)
1.6.3 Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Size (2016-2027)
1.6.4 Latin America Intravenous(IV) Therapy and Vein Access Market Size (2016-2027)
1.6.5 Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Size (2016-2027)

2 Intravenous(IV) Therapy and Vein Access Market Overview by Type
2.1 Global Intravenous(IV) Therapy and Vein Access Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Intravenous(IV) Therapy and Vein Access Historic Market Size by Type (2016-2021)
2.3 Global Intravenous(IV) Therapy and Vein Access Forecasted Market Size by Type (2022-2027)
2.4 Infusion Pumps
2.5 Implantable Ports
2.6 Intravenous Catheters
2.7 Hypodermic Needles
2.8 Other

3 Intravenous(IV) Therapy and Vein Access Market Overview by Application
3.1 Global Intravenous(IV) Therapy and Vein Access Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Intravenous(IV) Therapy and Vein Access Historic Market Size by Application (2016-2021)
3.3 Global Intravenous(IV) Therapy and Vein Access Forecasted Market Size by Application (2022-2027)
3.4 Hospital
3.5 Clinics
3.6 Other

4 Intravenous(IV) Therapy and Vein Access Competition Analysis by Players
4.1 Global Intravenous(IV) Therapy and Vein Access Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intravenous(IV) Therapy and Vein Access as of 2020)
4.3 Date of Key Players Enter into Intravenous(IV) Therapy and Vein Access Market
4.4 Global Top Players Intravenous(IV) Therapy and Vein Access Headquarters and Area Served
4.5 Key Players Intravenous(IV) Therapy and Vein Access Product Solution and Service
4.6 Competitive Status
4.6.1 Intravenous(IV) Therapy and Vein Access Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles and Key Data
5.1 B. Braun
5.1.1 B. Braun Profile
5.1.2 B. Braun Main Business
5.1.3 B. Braun Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
5.1.4 B. Braun Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2016-2021)
5.1.5 B. Braun Recent Developments
5.2 Baxter International
5.2.1 Baxter International Profile
5.2.2 Baxter International Main Business
5.2.3 Baxter International Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
5.2.4 Baxter International Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2016-2021)
5.2.5 Baxter International Recent Developments
5.3 Becton Dickinson
5.3.1 Becton Dickinson Profile
5.3.2 Becton Dickinson Main Business
5.3.3 Becton Dickinson Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
5.3.4 Becton Dickinson Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2016-2021)
5.3.5 C. R. Bard Recent Developments
5.4 C. R. Bard
5.4.1 C. R. Bard Profile
5.4.2 C. R. Bard Main Business
5.4.3 C. R. Bard Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
5.4.4 C. R. Bard Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2016-2021)
5.4.5 C. R. Bard Recent Developments
5.5 Fresenius Kabi
5.5.1 Fresenius Kabi Profile
5.5.2 Fresenius Kabi Main Business
5.5.3 Fresenius Kabi Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
5.5.4 Fresenius Kabi Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2016-2021)
5.5.5 Fresenius Kabi Recent Developments
5.6 Hospira(ICU Medical)
5.6.1 Hospira(ICU Medical) Profile
5.6.2 Hospira(ICU Medical) Main Business
5.6.3 Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
5.6.4 Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2016-2021)
5.6.5 Hospira(ICU Medical) Recent Developments
5.7 Medtronic
5.7.1 Medtronic Profile
5.7.2 Medtronic Main Business
5.7.3 Medtronic Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
5.7.4 Medtronic Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2016-2021)
5.7.5 Medtronic Recent Developments
5.8 Smiths Group
5.8.1 Smiths Group Profile
5.8.2 Smiths Group Main Business
5.8.3 Smiths Group Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
5.8.4 Smiths Group Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2016-2021)
5.8.5 Smiths Group Recent Developments
5.9 Teleflex
5.9.1 Teleflex Profile
5.9.2 Teleflex Main Business
5.9.3 Teleflex Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
5.9.4 Teleflex Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2016-2021)
5.9.5 Teleflex Recent Developments

6 North America
6.1 North America Intravenous(IV) Therapy and Vein Access Market Size by Country (2016-2027)
6.2 United States
6.3 Canada

7 Europe
7.1 Europe Intravenous(IV) Therapy and Vein Access Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe

8 Asia-Pacific
8.1 Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific

9 Latin America
9.1 Latin America Intravenous(IV) Therapy and Vein Access Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America

10 Middle East & Africa
10.1 Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa

11 Intravenous(IV) Therapy and Vein Access Market Dynamics
11.1 Intravenous(IV) Therapy and Vein Access Industry Trends
11.2 Intravenous(IV) Therapy and Vein Access Market Drivers
11.3 Intravenous(IV) Therapy and Vein Access Market Challenges
11.4 Intravenous(IV) Therapy and Vein Access Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
  • FORMAT: PDF
  • PUBLISHED DATE: May, 2021
  • NO OF PAGES: 125